Atovaquone
Top View
- Antiparasitic Evaluation of Betulinic Acid Derivatives Reveals Effective and Selective Anti-Trypanosoma Cruzi Inhibitors
- Use of a Doxycycline-Enrofloxacin
- Transformation with Human Dihydrofolate Reductase Renders Malaria Parasites Insensitive to WR99210 but Does Not Affect the Intrinsic Activity of Proguanil
- Appropriate Chemoprophylaxis Drugs by Country
- Identification of Trypanosoma Cruzi Growth Inhibitors with Activity In
- Drug-Free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule
- Anti-Malarial Medications for Chemoprophylaxis
- Localization of the Human Malaria Parasite's DHFR-TS and Examining
- The Medical Letter
- Amebic Meningoencephalitis.Qxd
- New Therapeutic Protocol for Canine Babesiosis: a Case Report
- Access to Essential Drugs in Poor Countries a Lost Battle?
- Atovaquone-Proguanil for Treating Uncomplicated Malaria (Review)
- MALARONE® (Atovaquone and Proguanil Hydrochloride) Tablets MALARONE® (Atovaquone and Proguanil Hydrochloride) Pediatric Tablets
- Cyclization-Blocked Proguanil As a Strategy to Improve the Antimalarial Activity of Atovaquone
- DARAPRIM® (Pyrimethamine) Oral Tablet PYRIMETHAMINE Oral Tablet
- Pyrimethamine (Daraprim®) EOCCO POLICY
- Revised 8/24/2020 GEORGIA MEDICAID FEE-FOR-SERVICE